Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity
- 12 January 2016
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (6) , 2643-2650
Abstract
Purpose Breast cancer survivors on aromatase inhibitors (AI) often experience side effects of joint pain, stiffness, or achiness (arthralgia). This study presents findings from a qualitative study of survivors on an AI regarding their knowledge of potential joint pain side effects and how both AI side effects and their management through moderate physical activity could be discussed during routine visits with their oncology provider. Methods Qualitative data from semi-structured interviews were content analyzed for emergent themes. Descriptive statistics summarize sample characteristics. Results Our sample included 36 survivors, mean age of 67 (range 46–87); 86 % Caucasian and 70 % had education beyond high school. AI experience are as follows: 64 % anastrozole/Arimidex, 48 % letrozole/Femara, and 31 % exemestane/Aromasin. Participants expressed interest in having more information about potential joint pain side effects when the AI was prescribed so they could understand their joint symptoms when they appeared or intensified. They were relieved to learn that their joint symptoms were not unusual or “in their head.” Participants would have been especially motivated to try walking as a way to manage their joint pain if physical activity had been recommended by their oncologist. Conclusions Breast cancer survivors who are prescribed an AI as part of their adjuvant treatment want ongoing communication with their oncology provider about the potential for joint pain side effects and how these symptoms may be managed through regular physical activity. The prescription of an AI presents a “teachable moment” for oncologists to recommend and encourage their patients to engage in regular physical activity.Keywords
Funding Information
- National Cancer Institute (R21CA169492)
This publication has 40 references indexed in Scilit:
- Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohortCancer, 2013
- Implementing the Exercise Guidelines for Cancer SurvivorsJournal of Supportive Oncology, 2012
- Aquatic exercise in a chest-high pool for hormone therapy-induced arthralgia in breast cancer survivors: a pragmatic controlled trialClinical Rehabilitation, 2012
- The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgiaBMC Cancer, 2011
- Impact of Yoga on Functional Outcomes in Breast Cancer Survivors With Aromatase Inhibitor–Associated ArthralgiasIntegrative Cancer Therapies, 2011
- Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivorsCancer, 2009
- Exercise and dietary change after diagnosis and cancer‐related symptoms in long‐term survivors of breast cancer: CALGB 79804Psycho-Oncology, 2008
- Cancer Survivors’ Adherence to Lifestyle Behavior Recommendations and Associations With Health-Related Quality of Life: Results From the American Cancer Society's SCS-IIJournal of Clinical Oncology, 2008
- Impact of aging on the biology of breast cancerCritical Reviews in Oncology/Hematology, 2008
- Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of CancerJournal of Clinical Oncology, 2005